intravascular lithotripsy

SHOCkwave lithotripsy for patients with peripheral arterial disease: the SHOCC study

May 22, 2024

Introduction Peripheral artery disease (PAD) represents a major health problem worldwide, affecting one-fifth of people over the age of 60 in the UK.1–3 It is the most common cause of lower limb amputation.4 Most patients with chronic limb threatening ischaemia (CLTI) and some patients with severe claudication will require lower limb revascularisation, one of the…

Read More

Use of Shockwave® intravascular lithotripsy in the treatment of calcific peripheral vascular disease of the crural vessels: a protocol for a systematic review

February 26, 2023

Introduction Peripheral artery disease (PAD) is a systemic atherosclerotic disease with an increasing prevalence currently estimated at over 230 million adults globally.1,2  PAD prevalence in the infrapopliteal/ crural arterial bed is increasing, influenced by the ageing population, as well as the increasing prevalence of diabetes and chronic kidney disease.1–3 Chronic limb-threatening ischaemia (CLTI), the most…

Read More